Breaking News Bar

Business News and Information

Aratana builds pet drug pipeline by buying rights from Japanese company

Aratana Therapeutics purchased exclusive rights to a pain treatment from Japanese drug developer AskAt Inc.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear